Skip to main content
SpringerLink
Log in

A Threat to the H2-Antagonist Ulcer Treatment Monopoly?

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

A Threat to the H2-Antagonist Ulcer Treatment Monopoly?. Inpharma Wkly. 647, 7 (1988). https://doi.org/10.1007/BF03308660

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03308660

Keywords

Search

Navigation